We are live on ! Find out more
FHTX icon

Foghorn Therapeutics

72 hedge funds and large institutions have $227M invested in Foghorn Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $34K | Put options by funds: $10K

44% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 16

28% more capital invested

Capital invested by funds: $177M → $227M (+$49.4M)

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

9.13% more ownership

Funds ownership: 62.16%71.29% (+9.1%)

4% more funds holding

Funds holding: 6972 (+3)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
72
Holders Change
+3
Holders Change %
+4.35%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
23
Reduced
16
Closed
13
Calls
$34K
Puts
$10K
Net Calls
+$24K
Net Calls Change
-$17K
Name Holding Trade Value Shares
Change
Change in
Stake
XT
76
XTX Topco
Cayman Islands
-$90.2K -13,448 Closed
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
-$77.3K -12,474 Closed
AIG
78
American International Group
New York
-$67.2K -10,018 Closed
Simplex Trading
79
Simplex Trading
Illinois
-$14K -2,119 Closed
Lazard Asset Management
80
Lazard Asset Management
New York
-$3K -548 Closed
Group One Trading
81
Group One Trading
Illinois
-$1.01K -151 Closed
AWM
82
Avior Wealth Management
Nebraska
-$20 -3 Closed
Zurich Cantonal Bank
83
Zurich Cantonal Bank
Switzerland
-$13 -2 Closed
Carson Wealth (CWM LLC)
84
Carson Wealth (CWM LLC)
Nebraska
+$95 +16 +1,600%

FHTX Hedge Fund Activity: Q2 2024 in Review

72 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q2 2024, worth a combined $227M — up 28% from $177M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new FHTX positions and 13 closed out — a net gain of 3 holders — while 23 added to existing stakes and 16 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $31.6M. The largest seller was Invesco, exiting entirely with an estimated $376K sold.

  • 72 institutional investors held Foghorn Therapeutics (FHTX) as of Q2 2024, up from 69 in Q1 2024.
  • Funds reported $227M of Foghorn Therapeutics stock for Q2 2024, up 28% quarter-over-quarter.
  • 16 funds opened new Foghorn Therapeutics positions in Q2 2024 and 13 closed out, a net change of +3 holders.
  • The largest Foghorn Therapeutics buyer in Q2 2024 was BVF Inc, an estimated $31.6M added.
  • The largest Foghorn Therapeutics seller in Q2 2024 was Invesco, an estimated $376K sold.

Based on aggregated 13F filings for Q2 2024.